Ken O'Flynn
Ceist:319. Deputy Ken O'Flynn asked the Minister for Health to provide the eligibility criteria, prescribing settings, and clinical governance requirements applying to the managed access system under which liraglutide (Saxenda) is reimbursed under the General Medical Services and Drugs Payment Schemes; and to provide the number of patients approved under this pathway in each of the years 2024 and 2025, and to date in 2026. [10658/26]
Amharc ar fhreagra